Showing results (171-180 of 213) with videos related to
Sort By:
Pageof 22
CNS Spectrums|January 6, 2025
Association of antidepressants with cataracts and glaucoma: a disproportionality analysis using the reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS) pharmacovigilance databaseGia Han Le, Sabrina Wong, Angela T H Kwan, et al.Journal of Affective Disorders|May 31, 2025
The prevalence, clinical impact, and therapeutic considerations of trauma in adults with bipolar disorder: A systematic reviewKelei Xiao, Hisham Sayed, Jason Xing, et al.Journal of Affective Disorders|August 9, 2023
Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorderShakila Meshkat, Kayla M Teopiz, Joshua D Di Vincenzo, et al.Journal of Affective Disorders|November 8, 2024
A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disordersHezekiah C T Au, Yang Jing Zheng, Gia Han Le, et al.Psychiatry Research|November 7, 2023
Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocolBrandon M Kitay, Eva Murphy, Matthew Macaluso, et al.Journal of Affective Disorders|July 17, 2024
Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic reviewSabrina Wong, Gia Han Le, Shreya Vasudeva, et al.Expert Opinion on Pharmacotherapy|March 22, 2024
Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic reviewAlexia Leber, Ranuk Ramachandra, Felicia Ceban, et al.Acta Neuropsychiatrica|February 13, 2026
The Effect of GLP-1 Receptor Agonists on Autophagy: Insights Gathered from Research Evaluating Neurodegenerative Disorders With These AgentsMaria-Christina Sioufi, Isabela Heroiu, Sabrina Wong, et al.Journal of Affective Disorders|September 20, 2024
Association between rumination, suicidal ideation and suicide attempts in persons with depressive and other mood disorders and healthy controls: A systematic review and meta-analysisGia Han Le, Sabrina Wong, Hezekiah Au, et al.Expert Opinion on Investigational Drugs|April 25, 2023
Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trialsGia Han Le, Emily S Gillissie, Taeho Greg Rhee, et al.Pageof 22